International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma

Rodriguez-Otero, P (author)

Usmani, S (author)

Cohen, AD (author)

show more...

van de Donk, NWCJ (author)

Leleu, X (author)

Gállego Pérez-Larraya, J (author)

Manier, S (author)

Nooka, AK (author)

Mateos, MV (author)

Einsele, H (author)

Minnema, M (author)

Cavo, M (author)

Derman, BA (author)

Puig, N (author)

Gay, F (author)

Ho, PJ (author)

Chng, WJ (author)

Kastritis, E (author)

Gahrton, G (author)

Karolinska Institutet

Weisel, K (author)

Nagarajan, C (author)

Schjesvold, F (author)

Mikhael, J (author)

Costa, L (author)

Raje, NS (author)

Zamagni, E (author)

Hájek, R (author)

Weinhold, N (author)

Yong, K (author)

Ye, JC (author)

Sidhana, S (author)

Merlini, G (author)

Martin, T (author)

Lin, Y (author)

Chari, A (author)

Popat, R (author)

Kaufman, JL (author)

show less...

 (creator_code:org_t)

2024

2024

English.

In: The Lancet. Oncology. - 1474-5488. ; 25:5, s. e205-e216

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)